FAIR VALUE MEASUREMENTS (Tables)

12 Months Ended

Dec. 31, 2015

Fair Value Disclosures [Abstract]

Schedule of Assets Measured at Fair Value

The Company's financial assets measured at fair value on a recurring basis consisted of the following types of instruments:

	As of December 31, 2015
	Fair value measurements using input type
	Level 1		Level 2		Level 3		Total
Investment in BioCancell	$	50	$	-	$	-	$	50

	As of December 31, 2015
	Fair value measurements using input type
	Level 1		Level 2		Level 3		Total
Investment in BioCancell	$	85	$	-	$	-	$	85